TY - JOUR KW - Buprenorphine KW - Cprd KW - drug safety KW - Methadone KW - Opioid use disorder KW - Overdose AU - E. Domzaridou AU - M. Carr AU - R. Webb AU - T. Millar AU - D. Ashcroft AD - National Institute for Health and Care Research Greater Manchester Patient Safety Translational Research Centre, Manchester Academic Health Science Centre, University of Manchester, UK. Centre for Pharmacoepidemiology and Drug Safety, Division of Pharmacy and Optometry, School of Health Sciences, Faculty of Biology, Medicine and Health, University of Manchester, UK. Centre for Mental Health and Safety, Division of Psychology and Mental Health, School of Health Sciences, Faculty of Biology, Medicine and Health, University of Manchester, UK. AN - 36034051 BT - Lancet Reg Health Eur C2 - PMC9399254 DO - 10.1016/j.lanepe.2022.100489 DP - NLM ET - 2022/08/30 LA - eng N1 - 2666-7762 Domzaridou, Eleni Carr, Matthew J Webb, Roger T Millar, Tim Ashcroft, Darren M Journal Article Lancet Reg Health Eur. 2022 Aug 11;22:100489. doi: 10.1016/j.lanepe.2022.100489. eCollection 2022 Nov. PY - 2022 SN - 2666-7762 EP - 100489 T2 - Lancet Reg Health Eur TI - Non-fatal overdose risk during and after opioid agonist treatment: A primary care cohort study with linked hospitalisation and mortality records VL - 22 ER -